Improving survival rates for patients with acute myeloid leukemia: Impacts of fludarabine/busulfan and antithymocyte globulin as reduced toxicity myeloablative conditioning for matched related donor allo-HCT.

Authors :: Yafour N
Serradj F
Osmani S
Brahimi M
Bouhass R
Arabi A
Bazarbachi A
Bekadja MA
Source :: Current research in translational medicine [Curr Res Transl Med] 2020 Nov; Vol. 68 (4), pp. 145-148. Date of Electronic Publication: 2020 Oct 04.
Publication Year :: 2020

Subjects :: Antilymphocyte Serum administration & dosage
Busulfan administration & dosage
Humans
Survival Rate
Transplantation Conditioning
Vidarabine therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Leukemia, Myeloid, Acute drug therapy
Vidarabine analogs & derivatives

Full Text Access

Tools